BBPvsFMEDETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.5% for FMED. BBP is up 22.38% year-to-date (YTD) with +$40M in YTD flows. FMED performs worse with 5.89% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of BBP and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs FMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP FMED | +1.64%+0.32% | +16.89%+15.70% | +22.38%+5.89% | +57.67%+19.34% | +76.64%+13.37% | +89.75%n/a |
| Flows | BBP FMED | +$10M- | +$28M-$17M | +$40M-$17M | +$52M-$14M | +$55M-$6M | +$48M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP FMED | +26.30%+22.34% | +23.98%+19.52% | +24.26%+18.58% | +26.44%n/a |
| Max drawdown | BBP FMED | -7.49%-5.92% | -9.59%-17.78% | -25.54%-21.42% | -37.61%n/a |
| Max drawdown duration | BBP FMED | 44d19d | 48d212d | 292d211d | 586dn/a |
Trading data
BBP | FMED | |
Last sale 7/29/2026 at 1:30 PM | $96.70 | |
| Previous close 07/28/2026 | $97.69 | |
| Consolidated volume 07/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FMED
is actively managed and doesn’t replicate an indexBBP | FMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/29/2026 at 1:30 PM
Live
Closed
BBP | FMED | |
|---|---|---|
| Last price | $96.70 | – |
| 1D performance | -1.02% | – |
| AuM | $97.61 M | $46.59 M |
| E/R | 0.34% | 0.5% |
Characteristics
BBP | FMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Fidelity |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 66 | 69 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | June 12, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
89.11%
Other
10.89%
FMED
USA
83.89%
Other
16.11%
Sectors
BBP
Healthcare
89.47%
Other
10.53%
FMED
Healthcare
100%
Other
-0%
Diversification
BBP
Total weight of top 15 holdings out of 15
87.15%
FMED
Total weight of top 15 holdings out of 15
41.87%
Top 15 holdings
Data as of June 30, 2026
BBP
Verastem, Inc.
44.58%
Legend Biotech Corp.
41.98%
Gilead Sciences, Inc.
0.05%
Incyte Corp.
0.05%
Zymeworks, Inc.
0.05%
Zai Lab Ltd.
0.05%
PTC Therapeutics, Inc.
0.05%
BioCryst Pharmaceuticals, Inc.
0.05%
Ionis Pharmaceuticals, Inc.
0.05%
Protagonist Therapeutics, Inc.
0.05%
Sarepta Therapeutics, Inc.
0.05%
Rhythm Pharmaceuticals, Inc.
0.05%
Kura Oncology, Inc.
0.05%
Arcutis Biotherapeutics, Inc.
0.05%
Geron Corp.
0.05%
FMED
Lifestance Health Group, Inc.
5.11%
10X Genomics, Inc.
3.56%
Danaher Corp.
3.29%
UCB SA
3.09%
Cogent Biosciences, Inc.
2.79%
Bio-Techne Corp.
2.76%
Moderna, Inc.
2.69%
Intuitive Surgical, Inc.
2.49%
argenx SE
2.43%
Alnylam Pharmaceuticals, Inc.
2.41%
Kymera Therapeutics, Inc.
2.36%
UnitedHealth Group, Inc.
2.27%
Thermo Fisher Scientific, Inc.
2.24%
Ascendis Pharma A/S
2.21%
Legend Biotech Corp.
2.17%
Frequently asked questions about BBP and FMED
How have the BBP and FMED ETFs performed in 2026?
As of July 28, 2026, BBP is up 22.38% year-to-date (YTD), while FMED has returned 5.89%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or FMED?
Year-to-date, the BBP ETF saw +$40M in flows, compared to -$17M for FMED.
Which ETF is more volatile: BBP or FMED?
Over the past year, BBP had a volatility of 23.98%, while FMED experienced 19.52%.
Which ETF is bigger: BBP or FMED?
As of July 28, 2026, BBP holds $97.61 M in assets under management (AUM), while FMED manages $46.59 M.
What sectors do the BBP and FMED ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.
What are the top holdings of the BBP ETF and FMED ETF?
BBP top holdings include Verastem, Inc., Legend Biotech Corp. and Gilead Sciences, Inc.. FMED holds in its top three: Lifestance Health Group, Inc., 10X Genomics, Inc. and Danaher Corp..
Which ETF is more diversified: BBP or FMED?
BBP holds 66 securities with 87.15% of its assets in the top 15. FMED has 69 securities and a top 15 weight of 41.87%.
Advertisement
Advertisement
